Chronic News and Research

RSS

Study highlights the role of intestinal T cells in modifying psychological stress responses

In experiments with mice and humans, a team led by Johns Hopkins Medicine researchers says it has identified a particular intestinal immune cell that impacts the gut microbiome, which in turn may affect brain functions linked to stress-induced disorders such as depression.

21 Mar 2023

Study suggests saliva samples may be better indicators of SARS-CoV-2 persistence than nasal swabs

In a recent study published in the PLOS ONE journal, researchers at Rutgers New Jersey Medical School explored the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human saliva.

21 Mar 2023

Real-world studies show efficacy, safety of BLV monotherapy in patients with HDV-related compensated cirrhosis

In 2020, bulevirtide (BLV) was conditionally approved for treating chronic hepatitis delta (CHD), an inflammation of the liver caused by hepatitis D virus (HDV).

20 Mar 2023

Playing tackle football at an early age increases risk for brain decline later

The degenerative brain disease known as CTE, or chronic traumatic encephalopathy, has become a specter haunting football.

20 Mar 2023

Study examines link between discrimination and accelerated aging in African American cancer survivors

Cancer and its treatment can accelerate the rate of aging because they both destabilize and damage biological systems in the body.

20 Mar 2023

Scientists uncover a link between cardiovascular disease and chronic kidney disease

Chronic kidney disease is linked to the formation of mineral deposits on blood vessel walls, known as "calcification", causing cardiovascular disease.

20 Mar 2023

COVID-19 patients more likely to develop gastrointestinal disorders

COVID-19 is associated with an increased risk of developing long-term gastrointestinal disorders, including irritable bowel syndrome.

20 Mar 2023

£3 million funding to support the development of new antimicrobials for cystic fibrosis patients

Today (16 March 2023), Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR) announces a £3 million Collaborative Discovery Programme for drug discovery innovators to accelerate the development of new treatments for people with CF.

20 Mar 2023

New WHO report identifies five core national targets for managing diabetes

A new report for the World Health Organization has identified five core national targets for UN member states aimed at reducing diabetes risk and ensuring that people with diabetes have equitable access to comprehensive and affordable care and prevention.

20 Mar 2023

What role does dysbiosis play in Parkinson's disease?

The current study, published in the journal Revue Neurologique, is based on the hypothesis that dysbiosis, or unhealthy variations in the gut and oral microbiota, is a key component of PD pathogenesis.

19 Mar 2023

Gut microbiomes and mental health: how do they interact?

A new study published in the journal Frontiers in Medicine reviewed recent literature on the link between gut microbiota, the brain, and neurological disorders.

19 Mar 2023

Biomarkers that can predict long COVID symptoms

The current study offered novel insights into the different biological factors that might contribute to long COVID.

19 Mar 2023

Which exercises might reduce pro-inflammatory and enhance anti-inflammatory cytokines in older people with mild cognitive impairment or Alzheimer's disease?

Researchers investigated which exercises might enhance anti-inflammatory cytokines and reduce pro-inflammatory cytokines in patients with dementia or mild cognitive impairment.

17 Mar 2023

Study confirms the benefit of Paxlovid as an early-stage treatment to prevent COVID-19 hospitalization

A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless of prior immunity or age.

17 Mar 2023

Monoclonal antibody-based blocking ELISA for SARS-CoV-2 detection in animals

In a recent study posted to the bioRxiv* preprint server, researchers in the United States described a blocking enzyme-linked immunosorbent assay (ELISA) to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure in animals.

16 Mar 2023

Is there an association between COVID-19 and an increased incidence of temporomandibular disorders?

Researchers assessed the association between COVID-19-related stress, depression, anxiety, and temporomandibular disorders from childhood to adulthood.

16 Mar 2023

Multivariate brain-wide associated studies can be replicable with substantially smaller sample sizes

Since the development of functional magnetic resonance imaging in the 1990s, the reliance on neuroimaging has skyrocketed as researchers investigate how fMRI data from the brain at rest, and anatomical brain structure itself, can be used to predict individual traits, such as depression, cognitive decline, and brain disorders.

16 Mar 2023

Phase 2 clinical trial investigates the effectiveness of innovative procedure to control Type 2 diabetes

More than 37 million Americans have diabetes, and approximately 90-95% have Type 2 diabetes.

16 Mar 2023

AI-based drug interaction prediction technology analyzes the interaction between Paxlovid ingredients

KAIST (President Kwang Hyung Lee) announced on the 16th that an advanced AI-based drug interaction prediction technology developed by the Distinguished Professor Sang Yup Lee's research team in the Department of Biochemical Engineering that analyzed the interaction between the PaxlovidTM ingredients that are used as COVID-19 treatment and other prescription drugs was published as a thesis.

16 Mar 2023

New definitions can specify high-risk comorbidity combinations for older surgical patients

A new way to identify more specific, higher-risk groups of older surgical patients can help in clinical decision-making and accurately comparing the performance of one hospital to another, according to research published in the Journal of the American College of Surgeons.

16 Mar 2023

Chronic News and Research

Study highlights the role of intestinal T cells in modifying psychological stress responses

Study suggests saliva samples may be better indicators of SARS-CoV-2 persistence than nasal swabs

Real-world studies show efficacy, safety of BLV monotherapy in patients with HDV-related compensated cirrhosis

Playing tackle football at an early age increases risk for brain decline later

Study examines link between discrimination and accelerated aging in African American cancer survivors

Scientists uncover a link between cardiovascular disease and chronic kidney disease

COVID-19 patients more likely to develop gastrointestinal disorders

£3 million funding to support the development of new antimicrobials for cystic fibrosis patients

New WHO report identifies five core national targets for managing diabetes

What role does dysbiosis play in Parkinson's disease?

Gut microbiomes and mental health: how do they interact?

Biomarkers that can predict long COVID symptoms

Which exercises might reduce pro-inflammatory and enhance anti-inflammatory cytokines in older people with mild cognitive impairment or Alzheimer's disease?

Study confirms the benefit of Paxlovid as an early-stage treatment to prevent COVID-19 hospitalization

Monoclonal antibody-based blocking ELISA for SARS-CoV-2 detection in animals

Is there an association between COVID-19 and an increased incidence of temporomandibular disorders?

Multivariate brain-wide associated studies can be replicable with substantially smaller sample sizes

Phase 2 clinical trial investigates the effectiveness of innovative procedure to control Type 2 diabetes

AI-based drug interaction prediction technology analyzes the interaction between Paxlovid ingredients

New definitions can specify high-risk comorbidity combinations for older surgical patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News